A cancer treatment based on synergy between anti-angiogenic and immune cell therapies.
about
Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.Integrated analysis of differential expression and alternative splicing of non-small cell lung cancer based on RNA sequencing.Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition.
P2860
A cancer treatment based on synergy between anti-angiogenic and immune cell therapies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A cancer treatment based on synergy between anti-angiogenic and immune cell therapies.
@en
type
label
A cancer treatment based on synergy between anti-angiogenic and immune cell therapies.
@en
prefLabel
A cancer treatment based on synergy between anti-angiogenic and immune cell therapies.
@en
P1476
A cancer treatment based on synergy between anti-angiogenic and immune cell therapies
@en
P2093
Luis Soto-Ortiz
P304
P356
10.1016/J.JTBI.2016.01.026
P407
P577
2016-01-27T00:00:00Z